[Special Stock] NineTech Pursues Mass Production and Commercialization of "Dream Material" MXene... In Supply Negotiations

NineTech is showing strong performance. Expectations for the commercialization of the next-generation material "MXene," which the company is pursuing as a new growth engine, appear to be influencing its stock price. NineTech announced that it is collaborating with a materials company in the mobility sector to commercialize MXene.

As of 10:00 a.m. on May 23, NineTech was trading at 3,100 won, up 6.16% from the previous day.

A NineTech representative stated on this day that the company is "in the negotiation stage regarding product supply" and explained, "Based on our precision manufacturing technology and quality control capabilities accumulated through our existing equipment business, we are able to mass-produce high-purity MXene and provide customized supply tailored to each application." The representative added, "We will lead a successful transition into a specialized materials company."

NineTech has completed the establishment of a new corporation dedicated to the MXene business and has built related production facilities.

NineTech is a company that has grown based on equipment for displays, semiconductors, and secondary batteries. Recently, the company has set expansion into the materials sector as a key mid- to long-term strategy. Starting with MXene, NineTech is accelerating its advanced functional materials business, focusing on stable revenue diversification and securing global technological competitiveness.

MXene is a two-dimensional nanomaterial in which metal and carbon atoms are alternately layered, characterized by high conductivity, mechanical flexibility, and surface modifiability. These properties make it optimal for a variety of high-value applications, including all-solid-state batteries, wearable devices, optoelectronic components, biosensors, and drug delivery systems.

While demand in the secondary battery and biomedical fields is surging, it is rare among domestic companies to simultaneously pursue both mass production and commercialization of MXene.